New book by Larry Connors Click here Improve your trading - See how
National Cancer Survivors Day is an annual, worldwide Celebration of Life held in hundreds of communities throughout the United States, Canada, and other countries. Participants unite in a symbolic event to show the world that life after a cancer diagnosis can be a reality.
"The original vision of TomoTherapy at its most basic level was to help cancer patients become cancer survivors," said Rock Mackie, Ph.D., co-founder and chairman of TomoTherapy. "Our solution was designed to offer an improved treatment option for many, including those with few (if any) other options left available to them. We, at TomoTherapy, see National Cancer Survivors Day as an opportunity to celebrate life. We are committed to educating people with cancer about new technologies that exist and to remind them that cancer is not the end, but the beginning, of a journey--and that you are not alone."
In honor of cancer survivors everywhere, TomoTherapy is featuring personal stories of survivors who have discovered the benefits of TomoTherapy treatment on their own. Watch these hopeful videos and read the stories to see how people have found power and strength in their cancer treatment choices. TomoVideo, the company's online video channel, now includes an in-depth interview with Dr. Mary Barnhart, a Portland, Ore.-based breast cancer surgeon turned cancer survivor.
After being diagnosed with advanced endometrial cancer and undergoing surgery and chemotherapy, Dr. Barnhart learned of TomoTherapy through extensive research on the best radiation option to fit her diet and lifestyle. She sought out TomoTherapy treatments at Meridian Park Radiation Oncology Center in Portland. "(TomoTherapy) was something that I truly needed to find," said Dr. Barnhart. "I found something that was perfect for me, and to know that it worked was just the best."
Dr. Barnhart's full video testimonial is available on TomoTherapy's TomoVideo.
Laurens Pierce III is another such survivor. As a late stage prostate cancer patient Laurens feared the results his treatment would have on his life and worried about debilitating side effects. He never imagined he could remain active while undergoing treatment. "During the whole time I was receiving Tomo(SM) treatments I never missed work. Never had a side effect," said Laurens Pierce. "I drove 100 miles to the clinic every day and came back to work....I never even missed my Sunday golf!"
Read more inspiring stories in TomoTherapy's Survivor Profiles.
In addition to the Survivor Profiles, TomoTherapy is connecting with patients outside of the treatment room. TomoTherapy is a proud sponsor and supporter of Radiate HopeSM, a non-profit organization dedicated to celebrating life and raising funds for cancer awareness, education, research, and treatment assistance. TomoTherapy and its employees believe the work of Radiate Hope helps cancer patients to live a longer, better quality of life. Additionally, TomoTherapy is on Twitter to share news, patient survivor stories and cancer research updates. Please join other survivors at http://twitter.com/tomo4patients.
About TomoTherapy Incorporated
TomoTherapy Incorporated has developed, markets and sells the TomoTherapy(R) Hi-Art(R) treatment system, an advanced radiation therapy system for the treatment of a wide variety of cancers. The Hi-Art treatment system combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. The company's stock is traded on the NASDAQ Global Select Market under the symbol TOMO. To learn more about TomoTherapy, please visit TomoTherapy.com.
(C)2009 TomoTherapy Incorporated. All rights reserved. TomoTherapy, the TomoTherapy logo and Hi-Art are among trademarks, service marks or registered trademarks of TomoTherapy Incorporated in the United States and other countries.
SOURCE: TomoTherapy Incorporated
TomoTherapy Incorporated Investor Contact: Stephen C. Hathaway Chief Financial Officer 608.824.2800 shathaway@tomotherapy.com or Media Contact: Kevin O'Malley Manager, Corporate Communications 608.824.3384 komalley@tomotherapy.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
